
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9943645
[patent_doc_number] => 08992944
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Purified Plasmodium and vaccine composition'
[patent_app_type] => utility
[patent_app_number] => 13/730281
[patent_app_country] => US
[patent_app_date] => 2012-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 13779
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13730281
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/730281 | Purified Plasmodium and vaccine composition | Dec 27, 2012 | Issued |
Array
(
[id] => 10443257
[patent_doc_number] => 20150328269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'PREPARATION FOR RADIO PROTECTION'
[patent_app_type] => utility
[patent_app_number] => 14/653543
[patent_app_country] => US
[patent_app_date] => 2012-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1463
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653543
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/653543 | PREPARATION FOR RADIO PROTECTION | Dec 18, 2012 | Abandoned |
Array
(
[id] => 10091281
[patent_doc_number] => 09128098
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Fuidi herd management and risk stratification methods'
[patent_app_type] => utility
[patent_app_number] => 13/690530
[patent_app_country] => US
[patent_app_date] => 2012-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 34862
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 381
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13690530
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/690530 | Fuidi herd management and risk stratification methods | Nov 29, 2012 | Issued |
Array
(
[id] => 11641031
[patent_doc_number] => 09662379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Vaccine for falciparum malaria'
[patent_app_type] => utility
[patent_app_number] => 14/361573
[patent_app_country] => US
[patent_app_date] => 2012-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 45
[patent_no_of_words] => 27611
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361573
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/361573 | Vaccine for falciparum malaria | Nov 29, 2012 | Issued |
Array
(
[id] => 8732704
[patent_doc_number] => 20130078273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'Vault Compositions For Immunization'
[patent_app_type] => utility
[patent_app_number] => 13/685552
[patent_app_country] => US
[patent_app_date] => 2012-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15733
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13685552
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/685552 | Vault Compositions For Immunization | Nov 25, 2012 | Abandoned |
Array
(
[id] => 11303221
[patent_doc_number] => 09510601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Yeast having resistance to freezing stress'
[patent_app_type] => utility
[patent_app_number] => 14/364411
[patent_app_country] => US
[patent_app_date] => 2012-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6226
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 275
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14364411
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/364411 | Yeast having resistance to freezing stress | Nov 19, 2012 | Issued |
Array
(
[id] => 8721181
[patent_doc_number] => 20130072398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis'
[patent_app_type] => utility
[patent_app_number] => 13/681224
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12940
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13681224
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/681224 | Compositions and methods for immunodominant antigens of Mycobacterium tuberculosis | Nov 18, 2012 | Issued |
Array
(
[id] => 8707562
[patent_doc_number] => 20130064851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'INACTIVATED STAPHYLOCOCCAL WHOLE-CELL VACCINE'
[patent_app_type] => utility
[patent_app_number] => 13/674835
[patent_app_country] => US
[patent_app_date] => 2012-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6964
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13674835
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/674835 | INACTIVATED STAPHYLOCOCCAL WHOLE-CELL VACCINE | Nov 11, 2012 | Abandoned |
Array
(
[id] => 8659538
[patent_doc_number] => 20130040367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'PHOSPHOTRIESTERASE FROM AGROBACTERIUM RADIOBACTER P230'
[patent_app_type] => utility
[patent_app_number] => 13/651250
[patent_app_country] => US
[patent_app_date] => 2012-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13572
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13651250
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/651250 | Phosphotriesterase from agrobacterium radiobacter P230 | Oct 11, 2012 | Issued |
Array
(
[id] => 11191547
[patent_doc_number] => 09422348
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-23
[patent_title] => 'Production of a cysteine rich protein'
[patent_app_type] => utility
[patent_app_number] => 14/123676
[patent_app_country] => US
[patent_app_date] => 2012-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 14675
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123676
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/123676 | Production of a cysteine rich protein | Oct 2, 2012 | Issued |
Array
(
[id] => 10355196
[patent_doc_number] => 20150240201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'MODIFIED BCG STRAINS WITH REDUCED OR ELIMINATED ACTIVITY OF LSR2 AND PHARMACEUTICAL COMPOSITION COMPRISING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/431875
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9788
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431875
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431875 | MODIFIED BCG STRAINS WITH REDUCED OR ELIMINATED ACTIVITY OF LSR2 AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Sep 26, 2012 | Abandoned |
Array
(
[id] => 8617235
[patent_doc_number] => 20130022547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'ATTENUATED MYCOPLASMA GALLISEPTICUM STRAINS'
[patent_app_type] => utility
[patent_app_number] => 13/626944
[patent_app_country] => US
[patent_app_date] => 2012-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4993
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13626944
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/626944 | ATTENUATED MYCOPLASMA GALLISEPTICUM STRAINS | Sep 25, 2012 | Abandoned |
Array
(
[id] => 8977221
[patent_doc_number] => 20130210651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'Borrelia Diagnostics and Screening Methods'
[patent_app_type] => utility
[patent_app_number] => 13/546165
[patent_app_country] => US
[patent_app_date] => 2012-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26884
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13546165
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/546165 | Borrelia diagnostics and screening methods | Sep 19, 2012 | Issued |
Array
(
[id] => 9311557
[patent_doc_number] => 08652773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Genes of an otitis media isolate of nontypeable Haemophilus influenza'
[patent_app_type] => utility
[patent_app_number] => 13/612176
[patent_app_country] => US
[patent_app_date] => 2012-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 58137
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13612176
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/612176 | Genes of an otitis media isolate of nontypeable Haemophilus influenza | Sep 11, 2012 | Issued |
Array
(
[id] => 9643138
[patent_doc_number] => 20140221251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'VIABLE GRAM NEGATIVE BACTERIA WITH REDUCED PROTEOLYTIC ACTIVITY LACKING OUTER MEMBRANE AGONISTS OF TLR4/MD-2'
[patent_app_type] => utility
[patent_app_number] => 14/343974
[patent_app_country] => US
[patent_app_date] => 2012-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 95
[patent_no_of_words] => 37407
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343974
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343974 | Viable gram negative bacteria with reduced proteolytic activity lacking outer membrane agonists of TLR4/MD-2 | Sep 6, 2012 | Issued |
Array
(
[id] => 8659494
[patent_doc_number] => 20130040323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'DETECTION KIT CONTAINING A NOVEL RECOMBINANT 15-kDA POLYPEPTIDE USEFUL FOR DETECTING HUMAN INFECTION WITH BARTONELLA HENSELAE'
[patent_app_type] => utility
[patent_app_number] => 13/588134
[patent_app_country] => US
[patent_app_date] => 2012-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11658
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13588134
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/588134 | Detection kit containing a novel recombinant 15-kDA polypeptide useful for detecting human infection with Bartonella henselae | Aug 16, 2012 | Issued |
Array
(
[id] => 8611892
[patent_doc_number] => 20130017204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae'
[patent_app_type] => utility
[patent_app_number] => 13/553006
[patent_app_country] => US
[patent_app_date] => 2012-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26624
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553006
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/553006 | Genes of an otitis media isolate of nontypeable Haemophilus influenzae | Jul 18, 2012 | Issued |
Array
(
[id] => 8916038
[patent_doc_number] => 20130177663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'Bacteriocins and Novel Bacterial Strains'
[patent_app_type] => utility
[patent_app_number] => 13/533037
[patent_app_country] => US
[patent_app_date] => 2012-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11360
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533037
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/533037 | Bacteriocins and Novel Bacterial Strains | Jun 25, 2012 | Abandoned |
Array
(
[id] => 8465134
[patent_doc_number] => 20120270301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'PROTEINS WITH REPETITIVE BACTERIAL-IG-LIKE (BIG) DOMAINS PRESENT IN LEPTOSPIRA SPECIES'
[patent_app_type] => utility
[patent_app_number] => 13/525157
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12000
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13525157
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/525157 | Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species | Jun 14, 2012 | Issued |
Array
(
[id] => 8976634
[patent_doc_number] => 20130210064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'MAGNETOTACTIC ALGAE AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/494533
[patent_app_country] => US
[patent_app_date] => 2012-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7853
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13494533
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/494533 | MAGNETOTACTIC ALGAE AND METHODS OF USE | Jun 11, 2012 | Abandoned |